A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Repligen Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 24,200 shares of RGEN stock, worth $3.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,200
Holding current value
$3.53 Million
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $2.9 Million - $4.43 Million
24,200 New
24,200 $3.05 Million
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $622,890 - $811,395
4,500 New
4,500 $636,000
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $467,451 - $748,083
-2,900 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $718,011 - $882,963
2,900 New
2,900 $768,000
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $1.36 Million - $1.81 Million
-8,200 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $1.15 Million - $1.45 Million
6,400 Added 355.56%
8,200 $1.59 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $2.71 Million - $3.78 Million
-18,300 Reduced 91.04%
1,800 $345,000
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $1.46 Million - $1.88 Million
11,900 Added 145.12%
20,100 $2.97 Million
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $773,506 - $1.15 Million
8,200 New
8,200 $1.01 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $435,656 - $549,172
-5,900 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $145,635 - $181,469
1,900 Added 47.5%
5,900 $452,000
Q2 2019

Aug 14, 2019

SELL
$54.2 - $85.95 $162,600 - $257,850
-3,000 Reduced 42.86%
4,000 $344,000
Q1 2019

May 15, 2019

SELL
$49.45 - $62.8 $143,405 - $182,120
-2,900 Reduced 29.29%
7,000 $414,000
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $477,774 - $681,912
9,900 New
9,900 $522,000
Q4 2017

Feb 14, 2018

SELL
$32.53 - $38.92 $1.2 Million - $1.44 Million
-37,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$36.98 - $46.06 $1.37 Million - $1.7 Million
37,000
37,000 $1.42 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.09B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.